Drug Abuse Aspects of HIV/AIDS (R21)
ArchivedNational Institutes of Health
Description
This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), encourages Exploratory/Developmental Research Grant (R21) applications to examine the drug abuse aspects of HIV/AIDS, including research on drug-related risk behaviors, addiction and HIV disease, and drug use/HIV-related co-morbidities and consequences. Applications are needed to identify and predict changes in the epidemiology of HIV/AIDS among injection and non-injection drug users and among their sexual partners; to develop and test interventions for primary and secondary HIV prevention, including drug treatment interventions; to improve HIV testing, counseling, and treatment services for those living with HIV/AIDS; and to address basic mechanisms involved in HIV infection and AIDS pathogenesis in the context of drug abuse and addiction.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
- PostedSep 25, 2012
- ClosesJan 7, 2016
- Award ceiling$200,000
- CFDA93.279
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro